rs57509953
- chr3-37025608-ATTTTTTTTT-A
- chr3-37025608-ATTTTTTTTT-AT
- chr3-37025608-ATTTTTTTTT-ATT
- chr3-37025608-ATTTTTTTTT-ATTT
- chr3-37025608-ATTTTTTTTT-ATTTT
- chr3-37025608-ATTTTTTTTT-ATTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTTTTTTTTT
- chr3-37025608-ATTTTTTTTT-ATTTTTTTTTTTTTTTTTT
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_000249.4(MLH1):c.1039-16_1039-8delTTTTTTTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene MLH1 is included in the ClinGen Criteria Specification Registry.
Frequency
Consequence
NM_000249.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MLH1 | MANE Select | c.1039-16_1039-8delTTTTTTTTT | splice_region intron | N/A | NP_000240.1 | P40692-1 | |||
| MLH1 | c.1039-16_1039-8delTTTTTTTTT | splice_region intron | N/A | NP_001341557.1 | A0A087WX20 | ||||
| MLH1 | c.940-16_940-8delTTTTTTTTT | splice_region intron | N/A | NP_001341558.1 | A0AAQ5BGZ2 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MLH1 | TSL:1 MANE Select | c.1039-28_1039-20delTTTTTTTTT | intron | N/A | ENSP00000231790.3 | P40692-1 | |||
| MLH1 | TSL:1 | c.1039-28_1039-20delTTTTTTTTT | intron | N/A | ENSP00000416687.3 | H0Y818 | |||
| MLH1 | TSL:1 | c.1039-28_1039-20delTTTTTTTTT | intron | N/A | ENSP00000416476.2 | H0Y806 |
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 258468Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 128320
GnomAD4 genome Cov.: 0
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at